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1956, tremendous advances in artificial intelligence (AI) have been
made, leading to applications using big data (BD) in numerous
fields from industry to finance, education, media, and telecom-
munications. In health care, the constant increase of computer
data led professionals, hospitals and states to take into consider-
ation the management of BD requiring AI and sophisticated
technical platforms to run the information systems (IS) of hospitals
together with extra-hospital data from connected devices.
AI in health care is needed as physician decisions are becoming
more evidence based, relying on guidelines and large databases as
opposed to solely schooling and expert opinion. Moreover,
considering the rising costs of health care worldwide, current in-
centives are also changing. States and private insurance companies
are switching from fee for service to plans that prioritise patient
outcomes. The rise of AI and BD is also answering that need.
Together with data analysts, clinicians should now take over the
development of AI and BD. If they fail to do so, it is likely they will
be quickly overwhelmed by high performance proprietary systems
from the commercial world, such as Google and Facebook. How-
ever, prerequisites are essential to make this digital transition.
Convergence of data requires collecting them from multiple
heterogeneous hospital databases and making the necessary
modifications to direct the data flows into a single BD warehouse.
Subsequently, it is necessary to clean and apply the correct algo-
rithm for AI with the help of data scientists (Fig. 1).
These new professions, at the interface of algorithm coding and
statistical analysis, well beyond the scope of current biostatistical
competencies, will lead to a major change at the very heart of the
medical profession. In Europe, experience with BD health care is
being built in pilot university hospitals with networks between
various hospitals to analyse millions of data. In this context,
feasibility studies involving the construction of cohorts leading to
multicentre studies are the first steps in the use of AI and BD.
These steps are made possible by the introduction of AI and
machine learning. AI is the ability of a machine to make an
autonomous decision based on data collected with a self learning
ability in repetitive data processing and adaptation to new data
evolving over time. In machine learning, a model learns from ex-
amples rather than being programmed with rules. A key difference
between human learning and machine learning is that humans can
learn to make general associations from small amounts of data.
For example, a child does not need many examples of a cat to
differentiate it from a dog. Machines require many more examples
than humans to learn the same task.
But AI for precise predictions about the distant future is some-
times risky. The rise and fall of Google Flu remind us that forecasting
an annual event based on one year’s data runs into time series
problems. The apparent solution is to pile on greater varieties of1078-5884/ 2020 European Society for Vascular Surgery. Published by
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By analysing BD, AI is constantly learning and introduces the
concept of predictivemedicine that has already proven itself in certain
areas, such as imaging, cancer, and dermatology to nameonly a few. AI
learning makes it possible to build diagnostic and therapeutic pro-
grammes adapted to a specific individual taking into account each of
his or her clinical, biological, and even genetic characteristics.
The management of BD results in a basket of patients provided
that the IS of hospitals makes its revolution by introducing new
professions and pedagogical work to insert it into the clinical
environment (Fig. 1). The interaction with medical practitioners is a
key point to guide engineers to avoid irrelevant clinical data being
analysed and thereby giving irrelevant results.
In Europe, the speed of implementation of these systems is not
happening as quickly as expected. The necessary economic in-
vestments and the paradigm shift has taken time, especially as public
authorities have also had to consider the protection of patient data
within the European Union’s General Data Protection Regulation,
which came into effect inMay 2018. Health systems have developed
sophisticated mechanisms to ensure the safe delivery of pharma-
ceutical agents to patients. The wide applicability of AI and BD will
require a similarly sophisticated regulatory oversight.
Hospitals in Paris are trialling BD and AI with machine learning
systems to forecast admission rates, aiming for a more efficient
deployment of resources and better patient outcomes. For this
purpose, at four of the hospitals that make up the Assistance Pub-
lique-Hôpitaux de Paris (AP-HP), data from internal and external
sources, including 10 years’ worth of hospital admissions records
and several external data sets such as weather, public holidays, and
flu patterns have been crunched to come up with day and hour level
predictions of the number of patients expected through the doors.
AI was employed to determine which algorithms provide the best
indicator of future trends when they are fed data from the past. The
system, built upon an open source platform, resulted in a web
browser based interface designed for doctors, nurses, and hospital
administration not trained in data science, to forecast visit and
admission rates for the next 15 days. Extra staff members were
drafted in when high numbers of visitors were expected, leading to
reducedwaiting times for patients and a better quality of care.1With
the cost of providing health care increasing at more than the rate of
gross domestic product in every developed country, smart, intelli-
gent systems like those of the AP-HP are likely to play an important
part in the future of health care. By more accurately predicting the
demand for services, waste can be reduced and insuring can become
more efficient.
Following oncology with genetic profiling now being used to
identify patients for whom tailored chemotherapy directed toward
personal cancer mutation is used,2 several applications derived
from AI are to be expected in vascular surgery with the manage-
ment of registries including clinical, biological, and imaging data.
Ross et al.3 built several models to identify peripheral arterial
disease (PAD) that frequently goes undiagnosed.4 They compared
their models to standard logistic regression and showed that AId Big Data in Health Care, European Journal of Vascular and Endovascular
Figure 1. What is big data? Using big data requires not only artificial intelligence, but also people
(1). Convergence of data requires collecting them from multiple heterogeneous databases to direct
the data flows into a single big data warehouse (2). At this point, data are left unprocessed (3).
Engineers deploy the infrastructure, clean the data, and make the data readable by an analysis
tool with the help of data scientists.  European Commission. Research and Innovation (https://
ec.europa.eu/growth/industry/innovation/business-innovation-observatory_en).
2 Editorialwas able to produce more accurate classification and predictive
models to identify patients with PAD and to predict mortality in a
population for which strong risk prediction models are lacking. For
example, Ross et al.3 used a variety of patient data, including
genomic, imaging, and socio-economic variables not obtainable
within the usual clinical research pathway to identify patients at
risk. As shown in the AP-HP experience, we will soon be able to
provide real time predictive analysis for patient care in large data
sets and to extract more granular information from the electronic
health records with natural language processing techniques.5
In vascular surgery, imaging is a key step in the care provided to
patients and several AI derived methods have been applied to
improve aortic aneurysm segmentation, allowing precise charac-
terisation of the aneurysm geometry with pre-operative modelling
for endograft insertion or to evaluate the risk of aortic aneurysm
growth and to predict outcomes after surgical repair.6e8 Pro-
grammes have also been developed for image segmentation and
risk stratification in patients with carotid artery stenosis.9 Finally,
AI has also been developed to enable simulation used for the
training in vascular surgery.10
These examples prove that the development of AI together with
BD is a major opportunity for vascular surgeons, as these tech-
niques have the potential to improve patient care, evidence based
medicine, education, and training. AI has raised promises but, on
the downside, has created hype derived from fantasy. There
remain many challenges to discover under the surface of the al-
gorithm black box.
The involvement of vascular surgeons in these technological
changes is therefore of utmost importance to guide vascular sci-
entists and industry to develop relevant applications and guar-
antee a safe and tailored use in clinical practice.
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